nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Are controlled trials of anticoagulation in children feasible?
|
Male, Christoph |
|
|
7 |
3 |
p. e193-e194 |
artikel |
2 |
Can virtual reality change the paediatric health-care experience?
|
Dunn, Amy L |
|
|
7 |
3 |
p. e195 |
artikel |
3 |
Catheter interventions: an unresolved clinical controversy
|
Avgerinos, Efthymios D |
|
|
7 |
3 |
p. e189 |
artikel |
4 |
Catheter interventions: an unresolved clinical controversy – Authors' reply
|
Notten, Pascale |
|
|
7 |
3 |
p. e190 |
artikel |
5 |
Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study
|
Myers, Kasiani C |
|
|
7 |
3 |
p. e238-e246 |
artikel |
6 |
Comparison of international societal guidelines for the diagnosis of suspected pulmonary embolism during pregnancy
|
Cohen, Stuart L |
|
|
7 |
3 |
p. e247-e258 |
artikel |
7 |
Correction to Lancet Haematol 2020; 7: e100–11
|
|
|
|
7 |
3 |
p. e191 |
artikel |
8 |
First-line dasatinib discontinuation in chronic myeloid leukaemia: another step towards an “operational cure”
|
Breccia, Massimo |
|
|
7 |
3 |
p. e182-e183 |
artikel |
9 |
Gene therapy 1·0 in haemophilia: effective and safe, but with many uncertainties
|
Makris, Michael |
|
|
7 |
3 |
p. e186-e188 |
artikel |
10 |
Idiopathic multicentric Castleman disease: bringing order to chaos
|
Leitch, Heather A |
|
|
7 |
3 |
p. e180-e181 |
artikel |
11 |
Imaging haemopoietic stem cells and microenvironment dynamics through transplantation
|
Williams, Kirsten M |
|
|
7 |
3 |
p. e259-e269 |
artikel |
12 |
Interferon-α: alternative first- or second-line therapeutic option for polycythaemia vera
|
Mascarenhas, John |
|
|
7 |
3 |
p. e178-e179 |
artikel |
13 |
Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study
|
Kiladjian, Jean-Jacques |
|
|
7 |
3 |
p. e226-e237 |
artikel |
14 |
Long-term safety of siltuximab in patients with idiopathic multicentric Castleman disease: a prespecified, open-label, extension analysis of two trials
|
van Rhee, Frits |
|
|
7 |
3 |
p. e209-e217 |
artikel |
15 |
Nursing impact on the CAR-T cell landscape
|
McDermott, Kathleen |
|
|
7 |
3 |
p. e192 |
artikel |
16 |
Plasma cell leukaemia presenting as flower-shaped plasma cells mimicking adult T-cell leukaemia or lymphoma
|
Shibusawa, Motoharu |
|
|
7 |
3 |
p. e270 |
artikel |
17 |
Polycythaemia vera, ruxolitinib, and hydroxyurea: where do we go now?
|
Spivak, Jerry L |
|
|
7 |
3 |
p. e184-e185 |
artikel |
18 |
Rare diseases: not so out of the ordinary
|
The Lancet Haematology, |
|
|
7 |
3 |
p. e177 |
artikel |
19 |
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
|
Gisslinger, Heinz |
|
|
7 |
3 |
p. e196-e208 |
artikel |
20 |
Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial
|
Kimura, Shinya |
|
|
7 |
3 |
p. e218-e225 |
artikel |